Icu Medical Inc./De

Interest, net We exclude interest in deriving adjusted EBITDA as interest can vary significantly among companies depending on a company's level of income generating instruments and or level of debt.

SEC original ↗Icu Medical Inc./De — Earnings release (8-K exhibit)EX-99Aug 7, 2025

Additionally, our definition of free cash flow is limited and does not represent residual cash flows available for discretionary expenditures due to the fact that the measure does not deduct the payments required for debt service and other obligations or payments made for business acquisitions.

SEC original ↗Icu Medical Inc./De — Earnings release (8-K exhibit)EX-99Aug 7, 2025

("OPF"); expected capital expenditures; anticipated consumer demand; supply chain constraints; timing and resolution of the 2025 Warning Letter (as defined below); the expected impact of macroeconomic developments, such as foreign exchange, inflation and interest rates, and new accounting and tax regulations; tariffs and the timing and receipt of any potential future refunds; the impact of the One Big Beautiful Bill Act (the "OBBBA"); as well as plans and objectives of management for future operations, are forward-looking statements.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

Fair value for services was estimated using a market approach based on observable margins for comparable services and the difference between the fair value of services and the estimated cost to provide the services through the term of the services agreement was discounted using our effective borrowing rate.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

Most of our leases do not provide an implicit rate; therefore, we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

Our team is focused on providing quality, innovation and value to our clinical customers worldwide.

SEC original ↗Icu Medical Inc./De — Earnings release (8-K exhibit)EX-99Aug 7, 2025

Restructuring, strategic transaction and integration We incur restructuring and strategic transaction charges that result from events, which arise from unforeseen circumstances and or often occur outside of the ordinary course of our ongoing business.

SEC original ↗Icu Medical Inc./De — Earnings release (8-K exhibit)EX-99Aug 7, 2025

All statements, other than statements of historical fact, contained in this Quarterly Report on Form 10-Q, including, without limitation, statements regarding: our future results of operations and financial position, including expected decreases in restructuring costs, business strategy and approach; the anticipated benefits and costs associated with our purchase agreement with Otsuka Pharmaceutical Factory America, Inc.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

Note 2: New Accounting Pronouncements Recently Issued Accounting Standards Not Yet Adopted In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements - Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

33-10532, Disclosure Update and Simplification Initiative, and align the ASC s requirements with the SEC s regulations.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

These forward-looking statements are based on management's current expectations, estimates, forecasts and projections about the Company and assumptions management believes are reasonable, all of which are subject to risks and uncertainties that could cause actual results and events to differ materially from those stated in the forward-looking statements.

SEC original ↗Icu Medical Inc./De — Earnings release (8-K exhibit)EX-99Aug 7, 2025

Legal Proceedings 52 Item1A.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

("OPF"); expected capital expenditures; anticipated consumer demand; supply chain constraints; timing and resolution of the 2025 Warning Letter (as defined below); the expected impact of macroeconomic developments, such as foreign exchange, inflation and interest rates, and new accounting and tax regulations; tariffs and the timing and receipt of any potential future refunds; the impact of the One Big Beautiful Bill Act (the "OBBBA"); as well as plans and objectives of management for future operations, are forward-looking statements.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026

In Note 6: Segment Data, amounts in the prior period significant segment expense table have been reclassified to conform to the current year presentation of standard cost of goods sold, other cost of goods sold, and tariffs and duties expense.

SEC original ↗Icu Medical Inc./De — 10-Q Quarterly report10-QAug 6, 2026